Tag Archives: costs

Skyrocketing drug prices put seniors’ health at risk

Liz Seegert

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in Kaiser Health News, The Atlantic.com, New America Media, AARP.com and other outlets. She is a senior fellow at the Center for Health, Media & Policy at Hunter College in New York City, and co-produces HealthStyles for WBAI-FM/Pacifica Radio.

Photo: Frankieleon via Flickr

Photo: Frankieleon via Flickr

The average price of brand-name prescription drugs rose almost 130 times faster than inflation in 2015 — 15.5 percent compared with 0.1 percent. New data points to increasing medication affordability problems for older adults, putting many of them at risk, according to a new report.

Researchers from the AARP Public Policy Institute studied trends in the retail prices of 268 brand name drugs widely used by older Americans between 2006 and 2015. Continue reading

Looking below the surface of those ‘outrageous hospital bill’ stories

Joseph Burns

About Joseph Burns

Joseph Burns (@jburns18), a Massachusetts-based independent journalist, is AHCJ’s topic leader on health insurance. He welcomes questions and suggestions on insurance resources and tip sheets at joseph@healthjournalism.org.

Photo: RikkisRefuge Other via Flickr

Photo: RikkisRefuge Other via Flickr

We may need a new hashtag to supplement #surprisemedbills. Perhaps #shockingmedbills would fit because some bills are just that.

Recent coverage about a new mom in Utah who was charged $39.35 just to hold her newborn is a good example. Continue reading

Need help navigating the current health care premium controversy?

Joanne Kenen

About Joanne Kenen

Joanne Kenen, (@JoanneKenen) the health editor at Politico, is AHCJ’s topic leader on health reform and curates related material at healthjournalism.org. She welcomes questions and suggestions on health reform resources and tip sheets at joanne@healthjournalism.org.

Photo: Mike Licht via Flickr

Buying health insurance – or understanding what our plans cover and how much we have to pay – isn’t easy. Moreover, the people we interview about their health plans and ACA shopping experiences can be just as confused as everyone else. Headlines about the health law and affordability and limited choices can confuse people, or make them assume their own costs are going up – which may not be true. Several million people who are eligible for ACA subsidies still aren’t getting them – and many don’t realize they may be eligible for financial assistance. Continue reading

Hospitals use algorithms to transform bad debt into charity care

Joanne Kenen

About Joanne Kenen

Joanne Kenen, (@JoanneKenen) the health editor at Politico, is AHCJ’s topic leader on health reform and curates related material at healthjournalism.org. She welcomes questions and suggestions on health reform resources and tip sheets at joanne@healthjournalism.org.

Photo: Andrew Magill via Flickr

Photo: Andrew Magill via Flickr

Bad debt? Or charity care? Sean Hamill of the Pittsburgh Post-Gazette recently wrote an interesting story about how hospitals increasingly are re-categorizing the health care bills of low-income patients in a fashion that may be helping the hospital more than the patient.

Some angles in this story are especially timely as the 2017 Affordable Care Act enrollment season is about to begin. Continue reading

Consumers Union expert weighs in on drug price hikes, other cost challenges

Susan Heavey

About Susan Heavey

Susan Heavey, (@susanheavey) a Washington, D.C.-based journalist, is AHCJ’s topic leader on social determinants of health and curates related material at healthjournalism.org. She welcomes questions and suggestions on resources and tip sheets at determinants@healthjournalism.org.

Lynn Quincy

Lynn Quincy

Mylan’s price hike for its EpiPen allergy medication is just the latest example of health care costs pressuring consumers, Consumers Union’s Lynn Quincy told AHCJ members in a recent webcast.

Quincy, who leads the consumer-advocacy group’s Healthcare Value Hub and has backed efforts to curb rising drug prices, pointed to other recent price increases such as those by drugmakers Valeant and Turing as symptoms of a massive “market failure.” Continue reading